Dysfunctions related to gephyrin-mediated neurotransmission have been implicated in several neurological disorders, such as neurodevelopmental disorders, epilepsy, and even neurodegenerative diseases like Alzheimer’s [84,85,86,87,88]. Here, GPHN is linked to nervous system disorder.